Borderline Personality Disorder, Mindfulness
Conditions
Brief summary
The current study aims to investigate the effect of dialectical behavioral therapy on mindfulness in patients with Borderline Personality Disorder. A treatment group will be compared to a waitlist control group.
Detailed description
Participants will be recruited from the Dialectical-Behavioral-Therapy (DBT) unit. DBT is a treatment approach that has been shown to be effective in the treatment of Borderline Personality Disorder. DBT integrates different psychotherapeutic interventions as well as Mindfulness Meditation exercises. Mindfulness is a meditation practice that can improve present moment awareness. When applied as therapeutic intervention mindfulness meditation can help patients to stay with their attention in the present moment, to be aware what is happening in the here and now, and to better identify and regulate upcoming emotions. The current observational study investigates changes in symptom severity and mindfulness skills during DBT treatment. A treatment group will be compared to a waitlist control group. The two groups are predefined by routine medical care. Symptom severity and mindfulness skills will be assessed at baseline (before treatment or when accepted for the waitlist) and after 12-weeks. A within and between group analyses will be performed.
Interventions
Inpatient Dialectical Behavioural Therapy (DBT) according to Linehan.
Sponsors
Study design
Eligibility
Inclusion criteria
* Clinical diagnosis of Borderline Personality Disorder * On the waitlist for DBT treatment or actually treated with DBT * Not previously treated with DBT.
Exclusion criteria
* Severe psychiatric comorbidity e.g. psychosis, severe depression, suicidality
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in mindfulness | Baseline and after 12-weeks | Degree of mindfulness will be assessed by the Kentucky Inventory of Mindfulness Skills, German Version (KIMS-D). A within and between group comparison will be performed (treatment vs. waitlist). |
| Change in borderline symptom severity | Baseline and after 12-weeks | Change in Borderline symptom severity is measured by the Borderline Symptom List (BSL 23). A within and between group comparison will be performed (treatment vs. waitlist). |
| Change in overall psychiatric symptom severity | Baseline and after 12-weeks | Change in overall symptom severity is measured by the Change in symptomseverity is measured by the Symptom-Checklist-90®-Standard (SCL-90). A within and between group comparison will be performed (treatment vs. waitlist). |
| Change in severity in symptoms of depression | Baseline and after 12-weeks | Change in overall symptom severity is measured by the Beck depression inventory (BDI). A within and between group comparison will be performed (treatment vs. waitlist). |
Countries
Germany